Abstract: A pharmaceutical composition for inhibiting Human Immunodeficiency Virus (HIV), which is characterized by comprising a compound represented by the formula (1) ##STR1## or a pharmaceutically acceptable salt thereof as an active ingredient.
Abstract: A method of lowering intraocular pressure in the eye of a human or an animal, the method involving administering to the eye, an agent comprising an amount of tetracycline or a tetracycline related compound, such as demeclocycline, sufficient to achieve a significant lowering of intraocular pressure.
Type:
Grant
Filed:
September 16, 1987
Date of Patent:
August 1, 1989
Assignee:
The Trustees of the University of Pennsylvania
Abstract: Disclosed herein is an aqueous solution containing a lipid-soluble active vitamin substance and/or ubiquinone. The solution has a pH of 5.5-8 and additionally contains a hydrogenated lecithin and neutral amino acid. It is stable and free from side effects, and is rather easy to prepare.